Journal of Biomedical Materials Research Part A · 2012 · 34 citations · 34 references
EngineeringBioengineeringBiomedical EngineeringBiocompatibilityInflammationTissue EngineeringBiomaterials For Tissue EngineeringCytokine BiologyMacrophage BiologyBiomaterial-macrophage InteractionsBiomedical ApplicationsInflammatory Cytokine EffectsMacrophage Inflammatory ResponsesMacrophage-mediated InflammationNanoparticle BiocompatibilitySilk BiomaterialsSilk Fibroin Biomaterials
Silk fibroin (SF) shows promise for tissue engineering and other biomedical applications due to its excellent biocompatibility, unique biomechanical properties, and controllable biodegradability. The particulate form of SF materials may have many potential uses, including the use as a filler for tissue defects or as a controlled-release agent for drug delivery. However, many past in vivo and in vitro studies evaluating the biocompatibility and biodegradability of SF have involved bulk implants. It is essential to evaluate the inflammatory effects of SF particles before further use. In this study, two different sizes of SF particles were evaluated to assess their impact on the release of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, in comparison with lipopolysaccharide positive control stimulation. The inflammatory processes were characterized using real-time reverse transcription polymerase chain reaction, enzyme-linked immunosorbent assay, and light microscopy evaluations. The results indicated that small silk fibroin particles and large silk fibroin particles, in culture with RAW 264.7 murine macrophage cells for 24 h, caused up-regulation of mRNA coding for TNF-α, which indicated that both size of particles have potential inflammatory effects. There was a statistically significant increase in this up-regulation under small silk fibroin stimulation. However, the immunosorbent assay suggested that there was virtually no observed release of IL-1β, IL-6, or TNF-α, relative to the control group. The results suggest that SF particles of the chosen dimensions may have good biocompatibility in culture with RAW 264.7 murine macrophages.
34
Bruce Panilaitis, Gregory H. Altman, Jingsong Chen et al. · Biomaterials · 2003 · 563 citations
Controlling silk fibroin particle features for drug delivery
Andreas Lammel, Xiao Hu, Sang‐Hyug Park et al. · Biomaterials · 2010 · 529 citations
Biologic effects of implant debris.
Nadim J. Hallab, Joshua J. Jacobs · PubMed · 2009 · 407 citations
Dentistry, Immunology, Biomaterials +16
Silk fibroin nanoparticles for cellular uptake and control release
Joydip Kundu, Yong-Il Chung, Young‐Ha Kim et al. · International Journal of Pharmaceutics · 2010 · 328 citations